P085 - Isolation of prostate cancer-specific circulating tumor cells for androgen receptor splice variant 7 analysis: The AdnaTest ProstateCancer versus the Gilupi CellCollector

Publication date: November 2018Source: European Urology Supplements, Volume 17, Issue 14Author(s): K. Ternov Kvorning, S.G. Jensen, P.B. Østergren, I. Balslev, M. Fode, H. Lindberg, C. Kistorp, R. Bisbjerg, G. Palapattu, J. Sønksen, E. Høgdall
Source: European Urology Supplements - Category: Urology & Nephrology Source Type: research

Related Links:

Contributor : Janet L StanfordSeries Type : Expression profiling by arrayOrganism : Homo sapiensPrognostic biomarkers are useful to screen patients with clinically localized prostate cancer (PCa) who are at high risk of metastatic progression. The tumor transcriptome can be used to evaluate the aggressiveness of PCa and predict adverse patient outcomes. Genomewide gene expression levels were measured in primary tumor samples of 503 patients in a population ‐based cohort.
Source: GEO: Gene Expression Omnibus - Category: Genetics & Stem Cells Tags: Expression profiling by array Homo sapiens Source Type: research
Future Oncology, Ahead of Print.
Source: Future Oncology - Category: Cancer & Oncology Authors: Source Type: research
MRI-guided transurethral ultrasound ablation can be performed on an outpatient basis, is noninvasive, has low side effects and, in the TACT trial, induced substantial reductions in PSA levels.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
American Journal of Roentgenology, Ahead of Print.
Source: American Journal of Roentgenology - Category: Radiology Authors: Source Type: research
ConclusionThere has been a recent resurgence on the interest of radical perineal prostatectomy for the treatment of localized PCa driven by the advent of new robotic surgical technologies into the field. Future studies are needed to better determine the learning curve of the perineal approach and its current role in the treatment of prostate cancer.
Source: World Journal of Urology - Category: Urology & Nephrology Source Type: research
Authors: Esteban Delgado P, Soria Aledo V Abstract Colorectal cancer (CRC) is one of the most relevant diseases worldwide because of its incidence, prevalence and mortalitye. It is the third most common tumor in men, after lung and prostate cancer, and the second most common tumor in women, after breast cancer. A recent systematic analysis showed global data referring to age-standardized incidence rates for CRC, which increased by 9.5% from 1990 to 2017, whereas mortality rates decreased by 13.5%. This might be due to the introduction of CRC prevention programs, which facilitate early identification and higher surv...
Source: Revista Espanola de Enfermedades Digestivas - Category: Gastroenterology Tags: Rev Esp Enferm Dig Source Type: research
Levels of potential biomarkers for prostate cancer in urine were comparable after a digital rectal examination in a physician's office and at a man's home.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Condition:   Prostate Cancer Intervention:   Drug: rhPSMA-7.3 (18F) Injection Sponsors:   Blue Earth Diagnostics;   Parexel Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Prostate Cancer Intervention:   Drug: rhPSMA-7.3 (18F) Injection Sponsors:   Blue Earth Diagnostics;   Parexel Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   D011471;   D064129;   D035683;   D009360;   D014408 Intervention:   Diagnostic Test: Periodic ARV7 and miRNA evaluation Sponsor:   Azienda Ospedaliero-Universitaria Careggi Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Prostate Cancer | Urology & Nephrology